News
SPOG invites you to the first SPOG Stakeholder Meeting on 21 June 2024 dedicated to childhood cancer research.
Listen to fascinating informative lectures and panel discussions on the topic of childhood cancer research in Switzerland and in the European context.
The event is open to anyone interested in the topic of childhood cancer research. The programme will include short presentations followed by panel discussions on the following topics: patient advocacy, research, regulations, policy and insurance. The event will be hosted by our president Prof. Dr. med. Katrin Scheinemann and Board member PD Dr. med. Dr. phil. Raffaele Renella.
This year’s core theme is: How do we do research together?
| Date | 21 June 2024, 10 a.m. to 12 noon, followed by a networking lunch |
| Location | Auditorium Rossi, Inselspital Bern |
| Cost | Participation free of charge, registration required (scroll down) |
| Programme | Download detailed programme |
Participating speakers:
- Nicole Scobie, Zoé4Life – patient advocacy
- Prof. Dr. med. Dr. sc. nat. Jean-Pierre Bourquin, University Children’s Hospital Zurich – research
- Isabelle Lamontagne-Müller, Swiss Paediatric Oncology Group (SPOG) – regulations
- Flavia Wasserfallen, Social Security and Health Committee of the Council of States – policy
- Dr. Luisa Bonafé, Service médical régional AI Suisse romande – insurance
Panel discussion guests:
- Prof. em. Dr. med. Markus Tolnay, Stiftung für krebskranke Kinder, Regio Basiliensis
- Prof. Dr. med. Rhoikos Furtwängler, Inselspital Bern
- Karin Flück Felder, Kinderkrebshilfe Zentralschweiz
- Christine Jean, Kinderkrebshilfe Schweiz
- Dr. Simone Ferbitz-Scheurer, Swissmedic
- Dr. pharm. Salome von Greyerz, Federal Office of Public Health (FOPH)
- Dr. Nicole Schaad, State Secretariat for Education, Research and Innovation (SBFI)
- Dr. Pietro Gervasoni, swissethics
- Dr. Michael Zeller, Swiss Paediatric Oncology Group (SPOG)
Register today and be part of our discussions on how we do research together – to give a future to children and adolescents with cancer.
